---
document_datetime: 2025-12-04 14:07:22
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/denosumab-intas-epar-all-authorised-presentations_en.pdf
document_name: denosumab-intas-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.7040679
conversion_datetime: 2025-12-29 21:24:09.818178
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) number      | (Invented) name   | Strength   | Pharmaceutical Form    | Route of Administration   | Immediate Packaging        | Content (concentration)   | Pack size            |
|---------------------|-------------------|------------|------------------------|---------------------------|----------------------------|---------------------------|----------------------|
| EU/1/25/19 93 /00 1 | Denosumab Intas   | 60 mg      | Solution for injection | Subcutaneous use          | pre-filled syringe (glass) | 1 ml (60 mg/ml)           | 1 pre-filled syringe |